Skip to main content
Clinical Trials/NCT05166720
NCT05166720CompletedNot Applicable

Clinical Application of the Best Evidence of NIDCAP in Very Low Birth Weight Infants

Children's Hospital of Fudan University1 site in 1 country14 target enrollmentStarted: March 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
14
Locations
1
Primary Endpoint
Mean length of stay of VLBWI

Study Overview

Brief Summary

In order to help THE GROWTH and development of VLBWI in Neonatal Intensive Care Unit (NICU) and reduce the interference of external environment to them, we summarized the best evidence of NIDCAP care, and applied the evidence to the intervention group, and observed the compliance of nurses in the intervention group to the application of evidence, and the short-term outcomes of VLBWI.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
— to 1 Day (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Birth weight <1500g;
  • admit within 24 hours of birth;
  • The guardian signs the informed consent;
  • OI (oxygenation index >300)

Exclusion Criteria

  • Newborn with severe congenital malformations or various chromosomal diseases, genetic metabolic diseases, severe neurological diseases;
  • Newborn who did not achieved discharge or death at the end of the study period

Outcomes

Primary Outcomes

Mean length of stay of VLBWI

Time Frame: From the day the VLBWI admitted to the day VLBWI discharged, about two months.

The average length of stay of VLBWI in the intervention group minus the average length of stay of VLBWI in the control group

Secondary Outcomes

  • Nurse compliance with NIDCAP evidence content(From the beginning of the NIDCAP intervention to the end of the NIDCAP intervention, about three months.)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials